In preeclampsia-like rat models, fisetin reduced the clinical and biochemical setting of PE by activation of Toll-like receptor 4 (TLR4)/NF-κB and NRF2/HO-1 pathways [127]. This evidence concerns the gene TLR4 and preeclampsia.